A Prospective, Randomized, Controlled, Study Evaluating EVICEL Fibrin Sealant as an Adjunct to Hemostasis During, Abdominal, Retroperitoneal or Pelvic Surgery in Pediatric Patients
Phase of Trial: Phase IV
Latest Information Update: 06 Aug 2019
Price : $35 *
At a glance
- Drugs Fibrinogen/thrombin (Primary) ; Oxidised cellulose
- Indications Surgical blood loss
- Focus Therapeutic Use
- Sponsors Ethicon
- 04 Aug 2019 This trial has been completed in Belgium (end date: 2019-05-17)
- 12 Dec 2017 Planned End Date changed from 1 Feb 2018 to 30 Nov 2019.
- 12 Dec 2017 Planned primary completion date changed from 1 Dec 2017 to 31 Oct 2019.